{ "items" : [
    { "id" : "http://dbpedia.org/resource/Belimumab"
      "properties" : {
        "http://www.w3.org/2000/01/rdf-schema#comment" : [ "Belimumab (trade name Benlysta, previously known as LymphoStat-B) is a human monoclonal antibody that inhibits B-cell activating factor (BAFF), also known as B-lymphocyte stimulator (BLyS). B cells are responsible for part of the normal immune response, and also for the over-aggressive immune response in autoimmune diseases like systemic lupus erythematosus (SLE).Belimumab is approved in the United States, Canada and Europe for treatment of SLE." ] ,
        "http://dbpedia.org/ontology/atcPrefix" : [ "L04" ] ,
        "http://dbpedia.org/ontology/atcSuffix" : [ "AA26" ] ,
        "http://dbpedia.org/ontology/casNumber" : [ "356547-88-1" ] ,
        "http://dbpedia.org/ontology/fdaUniiCode" : [ "73B0K5S26A"] } } }
